Lewis Rooney’s Post

View profile for Lewis Rooney, graphic

Head of Medtech & Digital Health - GQR Global Markets

Rock Health recently posted their breakdown of H1 funding within Digital Health and it definitely makes for interesting reading. With funding getting back to pre-pandemic levels, a few things are becoming evident: 1) Founders and Investors are finally beginning to sync up on what is important in early stage growth, focusing on proof of concept and a viable market fit over hyper growth and a tech style approach of ignoring profitability in order to gain users. 2) The talk of the pandemic accelerating the market by around 5 years can now clearly be seen as a false dawn, but that is not to say that there is not plenty to be optimistic about at the moment with a steady flow of strong funding rounds in recent months. 3) The industry has gone through a hard reset, the opportunism has left this space and moved on to "the next big thing". With this Digital Health as a market has settled into a sustainable place where it can continue to add value in the right places within the Healthcare ecosystem. Overall, the last couple of years working in this space has been tough, but I am now seeing a renewed optimism that existed in 2019 with a lot of good people building good products. Interested to hear other peoples thoughts on these figures, would you agree or disagree?

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics